Skip to content
Recall Observatory FDA recall evidence

Drug product

KETAmine Hydrochloride Injection, USP, 50 mg/5mL (10 mg/mL), For IM Use or Slow IV Use, 5 mL Sterile Single-Dose Vial, Rx Only, For Office Use Only, Compounded Durg by: Medivant Healthcare, 158 S. Kyrene Rd. Chandler, AZ 85226, NDC 81483-0006-0.

D-0500-2025

June 02, 2025

Class II

Product summary

Firm
Tailstorm Health INC
Event
Event 96996
Status
Ongoing
Classification
Class II
Quantity
23,200 vials
Official record key
drug-enforcement:D-0500-2025

Official wording

Reason: Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.

Code information: Lot #s: 2502008, Exp. 2/27/2027; 2503001, Exp. 3/4/2027.

Distribution pattern: Nationwide in the US

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility